Join the Prostate Cancer group to help and get support from people like you.
Prostate Cancer News (Page 5)
Related terms: Cancer, Prostate, Carcinoma of Prostate
For Prostate Cancer Info Videos, Patients Prefer Hearing From a Physician
FRIDAY, July 21, 2023 – Prostate cancer information delivered by video is considered more trustworthy when delivered by a physician versus a patient, according to a study published online July 19 in...
Black Patients More Likely to Trust Medical Videos When Black Doctor, Patient Is in It
THURSDAY, July 20, 2023 – The need to increase racial diversity among U.S. health care providers is important for many reasons. Among them, Black patients are more likely to believe Black physicians...
Adherence to Global Health Recommendations Cuts Risk for Some Cancers
TUESDAY, July 18, 2023 – Greater adherence to the 2018 World Cancer Research Fund/American Institute for Cancer Research Cancer Prevention Recommendations is associated with a lower risk for breast,...
New Type of Treatment Tackles Tough-to-Treat Prostate Cancer
THURSDAY, July 13, 2023 – A preclinical study offers a potential new therapy for treatment-resistant prostate cancer, offering new hope for men with the disease. The study used the chemotherapy drug...
Indigenous Men Less Likely to Receive PSA Testing
MONDAY, July 10, 2023 – Indigenous men are less likely to receive prostate-specific antigen (PSA) testing and are more likely to be diagnosed with higher-risk prostate cancer, according to a study...
Cardiorespiratory Fitness Tied to Reduced Cancer Incidence, Mortality in Men
MONDAY, July 3, 2023 – Higher levels of cardiorespiratory fitness (CRF) are associated with a reduced risk for incidence and mortality from specific cancers among men, according to a study published...
Certain Cancers Are on the Rise Among Hispanic Americans
MONDAY, July 3, 2023 – Cancer death rates among Hispanic Americans have declined in general over the past two decades, but for certain cancers the outlook has only gotten worse, a new study finds....
American Indian/Alaska Native Men Less Likely to Receive Prostate Screening
MONDAY, July 3, 2023 – American Indian/Alaska Native (AI/AN) men are less likely to receive a prostate-specific antigen test (PSAT) and/or digital rectal examination (DRE) during physician visits to...
FDA Approves Talzenna for Metastatic, Castration-Resistant Prostate Cancer
MONDAY, June 26, 2023 – The U.S. Food and Drug Administration has approved Talzenna (talazoparib) with enzalutamide for homologous recombination repair (HRR) gene-mutated metastatic...
Pfizer’s Talzenna (talazoparib) in Combination with Xtandi (enzalutamide) Receives U.S. FDA Approval for HRR Gene-Mutated Metastatic Castration-Resistant Prostate Cancer
NEW YORK--(BUSINESS WIRE) June 20, 2023 – Pfizer (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved Talzenna (talazoparib), an oral poly ADP-ribose polymerase...
ASCO: Drug Combo Ups Progression-Free Survival for Metastatic Prostate Cancer
THURSDAY, June 8, 2023 – For patients with metastatic castration-resistant prostate cancer (mCRPC), talazoparib plus enzalutamide results in improvement in radiographic progression-free survival...
Genetically Adjusted PSA Levels Improve Prediction of Prostate Cancer
WEDNESDAY, June 7, 2023 – Accounting for genetic determinants of constitutive, noncancer-related prostate-specific antigen (PSA) variation improves prediction of prostate cancer, according to a...
FDA Approves Lynparza for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer
TUESDAY, June 6, 2023 – The U.S. Food and Drug Administration approved Lynparza (olaparib) with abiraterone and prednisone (or prednisolone) for adult patients with deleterious or suspected...
FDA Approves Lynparza (olaparib) Plus Abiraterone and Prednisone or Prednisolone for Treatment of Adult Patients With BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Lynparza combination showed a clinically meaningful reduction in risk of disease progression or death in these patients in the Phase 3 PROpel trial First approval of a PARP inhibitor in combination...
ASCO: Germline Testing Underused in Cancer Patients
TUESDAY, June 6, 2023 – Few patients diagnosed with cancer between 2013 and 2019 in California and Georgia underwent germline testing, according to a study published online June 5 in the Journal of...
Ask a question
To post your own question to this support group, sign in or create an account.